- 期刊
Late-night-dinner deteriorates postprandial glucose and insulin whereas consuming dinner dividedly ameliorates them in patients with type 2 diabetes: A randomized crossover clinical trial
摘要
Background and Objectives: The aims of this study is to explore the acute effect of consuming dinner at different timing on postprandial glucose and hormone in patients with type 2 diabetes. Methods and Study Design: Eight patients (age 70.8±1.9 years, HbA1c 7.6±0.6 %, BMI 23.3±3.2, mean±SD) were randomly assigned in this crossover study. Patients consumed the test meals of dinner at 18:00 on the first day, and dinner at 21:00 or divided dinner (vegetable and rice at 18:00 and vegetable and the main dish at 21:00) on the second or third day. Postprandial glucose, insulin, glucagon, free fatty acid (FFA), active glucagon-like peptide-1 (GLP-1), and active glucose-dependent insulinotropic polypeptide (GIP) concentration after dinner were evaluated. Results: Both incremental area under the curve (IAUC) 2h for glucose and insulin were higher in dinner at 21:00 than those in dinner at 18:00 (IAUC glucose: 449±83 vs 216±43 mmol/L×min, p＜0.01, IAUC insulin:772±104 vs 527±107 μU/mL×min, p＜0.01, mean±SEM). However, in divided dinner both IAUC 4h for glucose and insulin tended to be lower than those of dinner at 21:00 (IAUC glucose: 269±76 mmol/L×min, p=0.070, IAUC insulin: 552±114 μU/mL×min, p=0.070). IAUC of active GLP-1 and active GIP demonstrated no difference among different dinner regimen. Conclusions: Consuming late-night-dinner (21:00) deteriorates postprandial glucose and insulin compared with those of early-evening-dinner (18:00) whereas consuming dinner dividedly ameliorates them.
延伸閱讀
- Tseng, K. B. (2021). The Clinical Landscape of Managing Type 2 Diabetes Patients with Chronic Kidney Disease with Sodium-Glucose Cotransporter-2 Inhibitors: Where are We Now and What can We Expect?. 內科學誌, 32(5), 322-332. https://doi.org/10.6314/JIMT.202110_32(5).03
- S, S., V, P., S, B., S, G., A, L., E, M., & L, D. E. (2017). Analysis of Clinical Outcome and Healthcare Resource use in Insulin Treated Diabetic Patients Based on Self-Monitoring of Blood Glucose Levels. International Journal of Diabetology & Vascular Disease Research (IJDVR), 5(2), 183-188. https://doi.org/10.19070/2328-353X-1700038
- Tura, A., Farngren, J., Schweizer, A., Foley, J. E., Pacini, G., & Ahren, B. (2015). Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin. International Journal of Endocrinology, 2015(), 147-153-118. https://doi.org/10.1155/2015/484231
- 黃麗卿、黃偉新、蘇釭惠、蔡一賢（2010）。Effect of a Reduced Calorie Diet Plan Versus a Partial Meal Replacement Plan on Weight Loss in Individuals with Metabolic Syndrome without Diabetes or Current Therapy with Lipid-lowering Agents。台灣家庭醫學雜誌，20(3)，122-131。https://doi.org/10.7023/TJFM.201009.0122
- Klupa, T., Mozdzan, M., Paszkot, J. K., Kubik, M., Masierek, M., Czerwinska, M., & Malecki, M. T. (2016). Diet-Related Knowledge and Physical Activity in a Large Cohort of Insulin-Treated Type 2 Diabetes Patients: PROGENS ARENA Study. International Journal of Endocrinology, 2016(), 241-246-026. https://doi.org/10.1155/2016/2354956